Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
TNF Inhibitor - an overview | ScienceDirect Topics
Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?
Current immunotherapy in rheumatoid arthritis | Immunotherapy
Infliximab - Wikipedia
Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis | Biomarkers in Medicine
Rheumatoid_Arthritis_Treatments_with_Biologics
How does infliximab work in rheumatoid arthritis? | Arthritis Research & Therapy | Full Text
New Drugs for Rheumatoid Arthritis | NEJM
Clinical Benefits of Switching from Original Infliximab to its Biosimilar (CT-P13) as a Potential TNF-α Inhibitor
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Emerging Mechanisms of Action and Loss of Response to Infliximab in Ibd: A Broader Picture
Development of anti-TNF therapy for rheumatoid arthritis | Nature Reviews Immunology
Infliximab Overview - Creative Biolabs
Emerging Mechanisms of Action and Loss of Response to Infliximab in Ibd: A Broader Picture | Semantic Scholar
The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease
IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
Golimumab Therapy of Rheumatoid Arthritis: An Overview - Zidi - 2010 - Scandinavian Journal of Immunology - Wiley Online Library
What is Infliximab (Remicade)?
Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists - ScienceDirect
Mechanisms of action of anti-TNF biologics. Anti-TNF biologics bind and... | Download Scientific Diagram
